Focus Session: Cutting Edge Regenerative Medicine Using Stem Cells
After Professor Shinya Yamanaka in Japan was awarded the Nobel Prize for the induction of iPS cells support has been given to make the clinical application of regeneration in Japan a reality by the All Japan. As a result, the world’s first clinical application of iPS was carried out. Clinical study and trial on retinal diseases (age-related macular degeneration) and Parkinson’s diseases have been started, in addition plans for research on spinal cord injuries and heart failure etc are scheduled. Studies using somatic stem cells are also being driven.
In this session we will introduce Japan's support system and announce the progress on regenerative medicine research in the clinical application stage, safety, and ethics, etc. There will also be talks about trends and efforts in regenerative medicine research in the UK and the US. At the end a discussion with the audience will be held regarding the future direction of research.
Presented by the Japan Agency for Medical Research and Development (AMED)